Abeona Therapeutics (ABEO) Leases (2019 - 2025)
Historic Leases for Abeona Therapeutics (ABEO) over the last 7 years, with Q3 2025 value amounting to $4.1 million.
- Abeona Therapeutics' Leases rose 783.85% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 783.85%. This contributed to the annual value of $3.6 million for FY2024, which is 2026.94% down from last year.
- Per Abeona Therapeutics' latest filing, its Leases stood at $4.1 million for Q3 2025, which was up 783.85% from $4.1 million recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' Leases ranged from a high of $9.4 million in Q4 2021 and a low of $3.6 million during Q4 2024
- In the last 5 years, Abeona Therapeutics' Leases had a median value of $4.9 million in 2023 and averaged $5.4 million.
- As far as peak fluctuations go, Abeona Therapeutics' Leases soared by 3371.73% in 2021, and later plummeted by 4330.53% in 2022.
- Abeona Therapeutics' Leases (Quarter) stood at $9.4 million in 2021, then tumbled by 43.31% to $5.3 million in 2022, then fell by 16.43% to $4.5 million in 2023, then dropped by 20.27% to $3.6 million in 2024, then grew by 15.03% to $4.1 million in 2025.
- Its last three reported values are $4.1 million in Q3 2025, $4.1 million for Q2 2025, and $4.2 million during Q1 2025.